Coronary heart disease and estrogen plus progestin treatment: the "burden" of the evidence

Coronary heart disease and estrogen plus progestin treatment: the "burden" of the evidence

Bibliographic Details
Main Author:	Álvaro Nagib Atallah
Format:	Article
Language:	English
Published:	Associação Paulista de Medicina 1999-03-01
Series:	São Paulo Medical Journal
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31801999000200001&lng=en&tlng=en

Similar Items

The Proliferative Response to p27 Down-Regulation in Estrogen Plus Progestin Hormonal Therapy is Lost in Breast Tumors
by: Mark D. Aupperlee, et al.
Published: (2018-04-01)

Progestin and aromatase inhibitor therapy in recurrent, estrogen/progestin receptor positive uterine carcinosarcoma: A case report
by: Angela L. Liang, et al.
Published: (2021-11-01)

Evidence for the treatment of chronic peptic ulcer
by: Álvaro Nagib Atallah

Estrogens and Progestins Cooperatively Shift Breast Cancer Cell Metabolism
by: Ashley V. Ward, et al.
Published: (2022-03-01)

Is the Expression of the Components of the Carotid Matrix of Rats Influenced by Estrogen, Progestin and Tibolone?
by: Marcelo Luis Steiner, et al.
Published: (2019-08-01)

Sources of evidence
by: Álvaro Nagib Atallah

Evidence-based medicine
by: Álvaro Nagib Atallah

Meta-analysis in evidence
by: Alvaro Nagib Atallah

The progestin revolution 2: progestins are now a dominant player in the tight interlink between contraceptive protection and bleeding control—plus more
by: Donna Shoupe
Published: (2023-10-01)

Evidence-based medicine in Brazil
by: Álvaro Nagib Atallah

The appraisal of medical scientific evidence
by: Álvaro Nagib Atallah

Upregulation of an estrogen receptor-regulated gene by first generation progestins requires both the progesterone receptor and estrogen receptor alpha
by: Meghan S. Perkins, et al.
Published: (2022-09-01)

Association of oxidative stress and memory performance in postmenopausal women receiving estrogen-progestin therapy
by: Shafin, Nazlahshaniza, et al.
Published: (2013)

Progestin plus metformin improves outcomes in patients with endometrial hyperplasia and early endometrial cancer more than progestin alone: a meta-analysis
by: Fengping Shao, et al.
Published: (2023-06-01)

Technological evaluations: the need for evidence-informed healthcare
by: Álvaro Nagib Atallah

Evidence-based healthcare for all: a new era?
by: Álvaro Nagib Atallah

Health technology assessments, evidence-based healthcare and health ethics
by: Álvaro Nagib Atallah

Pharmacological and metabolic effects of drospirenone as a progestin-only pill compared to combined formulations with estrogen
by: Pedro-Antonio Regidor, et al.
Published: (2023-02-01)

Comparative evaluation of raloxifene versus estrogen: Progestin on symptomatology, endometrium, and lipid profile in postmenopausal women
by: Anuradha Dogiparthi, et al.
Published: (2010-01-01)

Safety, efficacy and patient acceptability of the combined estrogen and progestin transdermal contraceptive patch: a review
by: Alessandra Graziottin
Published: (2008-11-01)

Right to health and not to be harmed: a definition from Evidence-Based Medicine
by: Álvaro Nagib Atallah

The Cochrane Collaboration: shared evidence for improving decision-making in human health
by: Álvaro Nagib Atallah
Published: (1999-09-01)

Evidence-based health care for all: support from the Brazilian Ministry of Health
by: Álvaro Nagib Atallah

COVID-19: better trustworthiness of clinical evidence through clinical trials and systematic reviews
by: Álvaro Nagib Atallah
Published: (2020-07-01)

Efficacy and effectiveness of treatment
by: Álvaro Nagib Atallah

Evidence-based health technology assessments for the Brazilian National Health System (Sistema Único de Saúde, SUS) and for all
by: Álvaro Nagib Atallah

The treatment and prevention of acute ischemic stroke
by: Alvaro Nagib Atallah

Evidence-based assessment of new technologies: good for Barack Obama's healthcare plan and good for Brazil, and at everyone's reach through HTAi Rio 2011
by: Álvaro Nagib Atallah

The economic burden of coronary heart disease in the UK.
by: Liu, J, et al.
Published: (2002)

Progestin and Nuclear Progestin Receptor Are Essential for Upregulation of Metalloproteinase in Zebrafish Preovulatory Follicles
by: Dong Teng Liu, et al.
Published: (2018-09-01)

Evidence in dentistry guidelines
by: Cristiane Rufino Macedo, et al.

Role of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidence
by: Maria Garefalakis, et al.
Published: (2008-03-01)

CARDIOPROTECTIVE PROPERTIES OF PROGESTINES: INFLUENCE OF DROSPIRENONE ON MYOCARD IN EXPERIMENTAL HEART FAILURE
by: Yu. V. Liskova, et al.
Published: (2017-07-01)

TREATMENT EFFECTIVENESS ANALYSIS OF OUTPATIENTS WITH ARTERIAL HYPERTENSION PLUS CORONARY HEART DISEASE IN UKRAINE
by: V. N. Kovalenko, et al.
Published: (2012-06-01)

Economic burden of coronary heart disease in North India
by: Akashdeep Singh Chauhan, et al.
Published: (2016-01-01)

Influence of gender and combined estrogen–progestin oral contraceptive on parotid saliva flow rate, pH, and electrolytes concentration
by: Angela Rovera, et al.
Published: (2024-02-01)

Ultrasonographic Observation of the Breast in Early Postmenopausal Women during Therapy with Cimicifuga Foetida Extract and Sequential Therapy with Estrogen and Progestin
by: Sharen Gaowa, et al.
Published: (2015-01-01)

Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database.
by: Shiori Hasegawa, et al.
Published: (2017-01-01)

Anticonceptivos orales de sólo progestina Progestin only-oral contraceptives
by: Alvaro Monterrosa
Published: (2006-03-01)

High Levels of Progesterone Receptor B in MCF-7 Cells Enable Radical Anti-Tumoral and Anti-Estrogenic Effect of Progestin
by: Natasa Bajalovic, et al.
Published: (2022-08-01)